Company intelligence / Profile preview

Truvic Lanka

Campbell, California, United States

Ownership: Private
Development stage: Other

Overview

Truvic is a medical technology company dedicated to developing innovative therapeutic solutions for peripheral vascular diseases, with a primary focus on venous thromboembolism (VTE). The company's portfolio includes advanced clot management systems designed to improve outcomes for patients suffering from pulmonary embolism and deep vein thrombosis. Founded as a spin-out from Imperative Care, Truvic was subsequently re-acquired to serve as a specialized vascular division. Its products aim to simplify complex endovascular procedures through high-performance mechanical thrombectomy technologies.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Truvic Lanka.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Truvic Lanka.

Explore the full profile